These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8025372)

  • 1. Antioxidant status, fatty acids, and cardiovascular disease.
    Hensrud DD; Heimburger DC
    Nutrition; 1994; 10(2):170-5. PubMed ID: 8025372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant status, erythrocyte fatty acids, and mortality from cardiovascular disease and Keshan disease in China.
    Hensrud DD; Heimburger DC; Chen J; Parpia B
    Eur J Clin Nutr; 1994 Jul; 48(7):455-64. PubMed ID: 7956986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet and cardiovascular diseases.
    Kromhout D
    J Nutr Health Aging; 2001; 5(3):144-9. PubMed ID: 11458283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary factors on oxidation of low-density lipoprotein particles.
    Lapointe A; Couillard C; Lemieux S
    J Nutr Biochem; 2006 Oct; 17(10):645-58. PubMed ID: 16517144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
    Aviram M
    Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants and atherosclerotic heart disease.
    Diaz MN; Frei B; Vita JA; Keaney JF
    N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidative modifications in atherosclerosis.
    Stocker R; Keaney JF
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of oxidative damage and antioxidant protection: assessment of LDL oxidation.
    Salonen JT
    Free Radic Res; 2000 Nov; 33 Suppl():S41-6. PubMed ID: 11191274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies.
    Willcox BJ; Curb JD; Rodriguez BL
    Am J Cardiol; 2008 May; 101(10A):75D-86D. PubMed ID: 18474278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single oral dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans.
    Linseisen J; Hoffmann J; Riedl J; Wolfram G
    Eur J Med Res; 1998 Feb; 3(1-2):5-12. PubMed ID: 9512961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of LDL fatty acid and carotenoid concentrations and oxidative resistance of LDL in volunteers from countries with different rates of cardiovascular disease.
    Wright AJ; Southon S; Chopra M; Meyer-Wenger A; Moser U; Granado F; Olmedilla B; Corridan B; Hinninger I; Roussel AM; van den Berg H; Thurnham DI
    Br J Nutr; 2002 Jan; 87(1):21-9. PubMed ID: 11898767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fat and cardiovascular disease risk: quantity or quality?
    Lichtenstein AH
    J Womens Health (Larchmt); 2003 Mar; 12(2):109-14. PubMed ID: 12737709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wine and cardiovascular disease.
    de Gaetano G; Cerletti C;
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4 Suppl):47-50. PubMed ID: 11894753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.